Nurix Therapeutics ($NRIX) Insider Trading & Smart Money Activity
Nurix Therapeutics, Inc. ($NRIX) has 6 insider trades and 4 analyst ratings on file. In the last 12 months on the open market, no insider bought and 5 insiders sold ($1.39M), net -$1.39M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 5
- Net insider $ (12 mo)
- -$1.39M
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 4
NRIX insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 2 · $688.32K | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 3 · $698.98K | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All NRIX insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Hansen GwennChief Scientific Officer | Sell (Open-market sale) 10b5-1 | 1.45K sh | $36.30K | Read | ||||||
| Insider | Gregory Julia PDirector | Sell (Open-market sale) | 22.58K sh | $528.53K | Read | ||||||
| Insider | Ring ChristineChief Legal Officer | Sell (Open-market sale) 10b5-1 | 5.79K sh | $134.15K | -2.8% | — | |||||
| Insider | Christine RingChief Legal Officer | Sell (Open-market sale) 10b5-1 | 28.93K sh | $580.44K | +6.7% | +4.3% | — | ||||
| Insider | Christine RingChief Legal Officer | Buy (Option exercise) | 28.93K sh | $232.85K | +6.7% | +4.3% | — | ||||
| Insider | Gwenn HansenChief Scientific Officer | Sell (Open-market sale) 10b5-1 | 5.39K sh | $107.88K | +6.7% | +4.3% | — | ||||
| Analyst | Baird | Reiterates to buy | PT $33 | +28.0% | +29.4% | Read | |||||
| Analyst | Needham | Reiterates to buy | PT $34 | +9.4% | +40.0% | Read | |||||
| Analyst | Truist Securities | Reiterates to buy | PT $32 | +9.1% | +57.9% | Read | |||||
| Analyst | Truist Securities | Reiterates to buy | PT $32 | +9.1% | +57.9% | — |
1W / 1M / 6M = how NRIX moved from the trade or filing date.
Insider trading in NRIX: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Hansen Gwenn | Chief Scientific Officer | 1 | -$36.30K | Oct 15, 2026 | |
| Gregory Julia P | Director | 1 | -$528.53K | Oct 14, 2026 | |
| Ring Christine | Chief Legal Officer | 1 | -$134.15K | Oct 2, 2026 | |
| Christine Ring | Chief Legal Officer | 2 | -$580.44K | Jun 25, 2026 | |
| Gwenn Hansen | Chief Scientific Officer | 1 | -$107.88K | Jun 25, 2026 |
Analyst ratings on NRIX
Frequently asked questions
Are NRIX insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 5 insiders made 5 open-market sales worth $1.39M, a net -$1.39M.
What is the latest insider trade in NRIX?
Hansen Gwenn, Chief Scientific Officer filed a sell (open-market sale) of 1.45K sh worth $36.30K on Oct 15, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.